Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target

Why Do Cancers Have High Aerobic Glycolysis?

Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784

The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation

DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppé, J., Tong, F. K., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,224

Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis

Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941

Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis

DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

Prat, A., Parker, J. S., Karginova, O. A., Fan, C., Livasy, C., Herschkowitz, J. I., He, X., & Perou, C. M. (2010) · Breast Cancer Research · doi:10.1186/bcr2635 · Cited by 2,290

c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism

Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124

Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction

Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001

Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy

Nicklin, P., Bergman, P., Zhang, B., Triantafellow, E., Wang, H., Nyfeler, B., Yang, H., Hild, M., Kung, C., Wilson, C., et al. (2009) · Cell · doi:10.1016/j.cell.2008.11.044 · Cited by 1,798

Glutamine addiction: a new therapeutic target in cancer

Wise, D. R., & Thompson, C. B. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.05.003 · Cited by 1,770

The Harmonious Interplay of Amino Acid and Monocarboxylate Transporters Induces the Robustness of Cancer Cells

Yoshida, G. J. (2021) · Metabolites · doi:10.3390/metabo11010027 · Cited by 32

Multimodal polymer encapsulated CdSe/Fe3O4 nanoplatform with improved biocompatibility for two-photon and temperature stimulated bioapplications

Antoniak, M. A., Pązik, R., Bazylińska, U., Wiwatowski, K., Tomaszewska, A., Kulpa-Greszta, M., Adamczyk‐Grochala, J., Wnuk, M., Maćkowski, S., Lewińska, A., et al. (2021) · Materials Science and Engineering C · doi:10.1016/j.msec.2021.112224 · Cited by 31

Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments

Gómez-Cebrián, N., Domingo-Ortí, I., Poveda, J. L., Vicent, M. J., Puchades‐Carrasco, L., & Pineda‐Lucena, A. (2021) · Cancers · doi:10.3390/cancers13184544 · Cited by 32

Phytochemicals Targeting Ferroptosis: Therapeutic Opportunities and Prospects for Treating Breast Cancer

Zhao, X., Wang, X., & Pang, Y. (2022) · Pharmaceuticals · doi:10.3390/ph15111360 · Cited by 32

Cycloplatinated (II) Complex Based on Isoquinoline Alkaloid Elicits Ferritinophagy-Dependent Ferroptosis in Triple-Negative Breast Cancer Cells

Wang, F.-Y., Yang, L.-M., Wang, S., Lu, H. J., Wang, X., Lu, Y., Ni, W., Liang, H., & Huang, K.-B. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00285 · Cited by 30

Amino acid metabolism in breast cancer: pathogenic drivers and therapeutic opportunities

Liu, Y., Zong, X., Altea‐Manzano, P., & Fu, J. (2025) · Protein & Cell · doi:10.1093/procel/pwaf011 · Cited by 32

Glutamine deprivation plus BPTES alters etoposide- and cisplatin-induced apoptosis in triple negative breast cancer cells

Chen, L., Cui, H., Fang, J., Deng, H., Kuang, P., Guo, H., Wang, X., & Zhao, L. (2016) · Oncotarget · doi:10.18632/oncotarget.10579 · Cited by 30

Identification of capsazepine as a novel inhibitor of system xc− and cancer-induced bone pain

Fazzari, J., Balenko, M. D., Zacal, N., & Singh, G. (2017) · Journal of Pain Research · doi:10.2147/jpr.s125045 · Cited by 29

SLC25A22 promotes proliferation and metastasis by activating MAPK/ERK pathway in gallbladder cancer

Du, P., Liang, H., Fu, X., Wu, P., Wang, C., Chen, H., Zheng, B., Zhang, J., Hu, S., Zeng, R., et al. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0746-9 · Cited by 29

Emerging strategies to target cancer metabolism and improve radiation therapy outcomes

Kery, M., & Papandreou, I. (2020) · British Journal of Radiology · doi:10.1259/bjr.20200067 · Cited by 33

Revisiting Tumors and the Cardiovascular System: Mechanistic Intersections and Divergences in Ferroptosis

Wang, Y., Peng, X., Zhang, M., Jia, Y., Yu, B., & Tian, J. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9738143 · Cited by 30

Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies

Magri, J., Gasparetto, A., Conti, L., Calautti, E., Cossu, C., Ruiu, R., Barutello, G., & Cavallo, F. (2021) · Cells · doi:10.3390/cells10010108 · Cited by 31

Breast cancer cells that preferentially metastasize to lung or bone are more glycolytic, synthesize serine at greater rates, and consume less ATP and NADPH than parent MDA-MB-231 cells

Jekabsons, M. B., Merrell, M., Skubiz, A. G., Thornton, N., Milasta, S., Green, D. R., Chen, T., Wang, Y., Avula, B., Khan, I. A., et al. (2023) · Cancer & Metabolism · doi:10.1186/s40170-023-00303-5 · Cited by 29

Administering xCT Inhibitors Based on Circadian Clock Improves Antitumor Effects

Okazaki, F., Matsunaga, N., Hamamura, K., Suzuki, K., Nakao, T., Okazaki, H., Kutsukake, M., Fukumori, S., Tsuji, Y., & To, H. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0720 · Cited by 29

Discovery and optimization of withangulatin A derivatives as novel glutaminase 1 inhibitors for the treatment of triple-negative breast cancer

Zhou, W.-X., Chen, C., Liu, X., Li, Y., Lin, Y., Wu, X.-T., Kong, L., & Luo, J. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112980 · Cited by 28

Long non-coding RNAs affecting cell metabolism in cancer

Agostini, M., Mancini, M., & Candi, E. (2022) · Biology Direct · doi:10.1186/s13062-022-00341-x · Cited by 29

Anti-tumor effect of sulfasalazine in neuroblastoma

Mooney, M. R., Geerts, D., Kort, E. J., & Bachmann, A. S. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.01.007 · Cited by 28

Exploring Amino Acid Transporters as Therapeutic Targets for Cancer: An Examination of Inhibitor Structures, Selectivity Issues, and Discovery Approaches

Jakobsen, S., & Nielsen, C. U. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16020197 · Cited by 28

Tumor Metabolic Reprogramming and Ferroptosis: The Impact of Glucose, Protein, and Lipid Metabolism

Zhu, K., Cai, Y., Lan, L., & Luo, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413413 · Cited by 33

Urolithin A and B Alter Cellular Metabolism and Induce Metabolites Associated with Apoptosis in Leukemic Cells

Alzahrani, A. M., Mohammed, M. R. S., Alghamdi, R., Ahmad, A., Zamzami, M. A., Choudhry, H., & Khan, M. I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115465 · Cited by 27

A glutamine ‘tug-of-war’: targets to manipulate glutamine metabolism for cancer immunotherapy

Pallett, L. J., Dimeloe, S., Sinclair, L. V., Byrne, A. J., & Schurich, A. (2021) · Immunotherapy Advances · doi:10.1093/immadv/ltab010 · Cited by 28

Ferroptosis, Metabolic Rewiring, and Endometrial Cancer

Žalytė, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010075 · Cited by 29

Disruption of redox balance in glutaminolytic triple negative breast cancer by inhibition of glutaminase and glutamate export

Choi, H., Gupta, M., Sengupta, A., Furth, E. E., Hensley, C., Weljie, A. M., Lee, H. S., Lu, Y., Pantel, A., Mankoff, D. A., et al. (2025) · Neoplasia · doi:10.1016/j.neo.2025.101136 · Cited by 27

Novel impact of the DNMT3A R882H mutation on GSH metabolism in a K562 cell model established by TALENs

Yang, L., Liu, Y., Zhang, N., Ding, X., Zhang, W., Shen, K., Huang, L., Zhou, J., Cui, S., Zhu, Z., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16449 · Cited by 28

Glutamine Transporter SLC1A5 Regulates Ionizing Radiation‐Derived Oxidative Damage and Ferroptosis

Yuan, Z., Liu, T., Huo, X., Wang, H., Wang, J., & Xue, L. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3403009 · Cited by 26

A comprehensive overview of recent developments on the mechanisms and pathways of ferroptosis in cancer: the potential implications for therapeutic strategies in ovarian cancer

Kobayashi, H., Yoshimoto, C., Matsubara, S., Shigetomi, H., & Imanaka, S. (2023) · Cancer Drug Resistance · doi:10.20517/cdr.2023.49 · Cited by 25

SIRT5 Activation and Inorganic Phosphate Binding Reduce Cancer Cell Vitality by Modulating Autophagy/Mitophagy and ROS

Barreca, F., Aventaggiato, M., Vitiello, L., Sansone, L., Russo, M. A., Mai, A., Valente, S., & Tafani, M. (2023) · Antioxidants · doi:10.3390/antiox12081635 · Cited by 24

Targeting ferroptosis: a promising strategy to overcome drug resistance in breast cancer

Peng, C., Chen, Y., & Jiang, M. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1499125 · Cited by 28

Lrp5 Has a Wnt-Independent Role in Glucose Uptake and Growth for Mammary Epithelial Cells

Chin, E. N., Martin, J. A., Kim, S. Y., Fakhraldeen, S. A., & Alexander, C. M. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00800-15 · Cited by 23

Transcription Factors in Breast Cancer—Lessons From Recent Genomic Analyses and Therapeutic Implications

Zacksenhaus, E., Liu, J.-K., Jiang, Z., Yao, Y., Xia, L., Shrestha, M., & Ben‐David, Y. (2016) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2016.10.003 · Cited by 28

Low Expression of SLC7A11 Confers Drug Resistance and Worse Survival in Ovarian Cancer via Inhibition of Cell Autophagy as a Competing Endogenous RNA

Ke, Y., Chen, X., Su, Y., Chen, C., Lei, S., Xia, L., Wei, D., Zhang, H., Dong, C., Liu, X., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.744940 · Cited by 25

Cystine/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system function in breast cancer mouse models

Ruiu, R., Cossu, C., Iacoviello, A., Conti, L., Bolli, E., Ponzone, L., Magri, J., Rumandla, A., Calautti, E., & Cavallo, F. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02830-x · Cited by 25

Induction of Oxidative Stress and Ferroptosis in Triple-Negative Breast Cancer Cells by Niclosamide via Blockade of the Function and Expression of SLC38A5 and SLC7A11

Mathew, M., Sivaprakasam, S., Dharmalingam-Nandagopal, G., Sennoune, S. R., Nguyen, N. T. H., Jaramillo‐Martinez, V., Bhutia, Y. D., & Ganapathy, V. (2024) · Antioxidants · doi:10.3390/antiox13030291 · Cited by 25

The potential of inhibiting glutamine uptake as a therapeutic target for multiple myeloma

Giuliani, N., Chiu, M., Bolzoni, M., Accardi, F., Bianchi, M. G., Toscani, D., Aversa, F., & Bussolati, O. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1279148 · Cited by 25

Metabolic Reprogramming of Cancer Cells and Therapeutics Targeting Cancer Metabolism

Punnasseril, J. M. J., Auwal, A., Gopalan, V., Lam, A. K.-Y., & Islam, F. (2025) · Cancer Medicine · doi:10.1002/cam4.71244 · Cited by 28

Crosstalk between Immune Checkpoint Modulators, Metabolic Reprogramming and Cellular Plasticity in Triple-Negative Breast Cancer

Poddar, A., Rao, S. R., Prithviraj, P., Kannourakis, G., & Jayachandran, A. (2022) · Current Oncology · doi:10.3390/curroncol29100540 · Cited by 24

Tamoxifen therapy benefit predictive signature coupled with prognostic signature of post-operative recurrent risk for early stage ER+ breast cancer

Cai, H., Li, X., Li, J., Ao, L., Yan, H., Tong, M., Guan, Q., Li, M., & Guo, Z. (2015) · Oncotarget · doi:10.18632/oncotarget.6260 · Cited by 23

Pharmacologic approaches to amino acid depletion for cancer therapy

Wilder, C. S., Chen, Z., & DiGiovanni, J. (2021) · Molecular Carcinogenesis · doi:10.1002/mc.23349 · Cited by 23

Metabolomics and EMT Markers of Breast Cancer: A Crosstalk and Future Perspective

Pal, A. K., Sharma, P., Zia, A., Siwan, D., Nandave, D., Nandave, M., & Gautam, R. K. (2022) · Pathophysiology · doi:10.3390/pathophysiology29020017 · Cited by 23

A metabolic investigation of anticancer effect of G. glabra root extract on nasopharyngeal carcinoma cell line, C666-1

Zheng, C., Han, L., & Wu, S. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-04828-1 · Cited by 23

Glutamatergic system components as potential biomarkers and therapeutic targets in cancer in non-neural organs

García-Gaytán, A. C., Hernández-Abrego, A., Díaz‐Muñoz, M., & Méndez, I. G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1029210 · Cited by 27

Amino acid metabolic reprogramming in the tumor microenvironment and its implication for cancer therapy

Zhang, J., Chen, M., Yang, Y., Liu, Z., Guo, W., Xiang, P., Zeng, Z., Wang, D., & Xiong, W. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31349 · Cited by 23

NDRG2 ablation reprograms metastatic cancer cells towards glutamine dependence via the induction of ASCT2

Ding, M., Bu, X., Li, Z., Xu, H., Feng, L., Hu, J., Wei, X., Gao, J., Tao, Y., Cai, B., et al. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.48066 · Cited by 21

Metabolic reprogramming and metabolic sensors in KSHV-induced cancers and KSHV infection

Li, T., & Gao, S. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00688-0 · Cited by 21

PTGER3 knockdown inhibits the vulnerability of triple‐negative breast cancer to ferroptosis

Wang, S., Zhang, Y., Zhang, D., Meng, J., Che, N., Zhao, X., & Liu, T. (2024) · Cancer Science · doi:10.1111/cas.16169 · Cited by 20

Impaired anaplerosis is a major contributor to glycolysis inhibitor toxicity in glioma

Khadka, S., Arthur, K., Barekatain, Y., Behr, E., Washington, M., Ackroyd, J. J., Crowley, K., Suriyamongkol, P., Lin, Y.-H., Pham, C.-D., et al. (2021) · Cancer & Metabolism · doi:10.1186/s40170-021-00259-4 · Cited by 21

Polarity protein SCRIB interacts with SLC3A2 to regulate proliferation and tamoxifen resistance in ER+ breast cancer

Saito, Y., Matsuda, S., Ohnishi, N., Endo, K., Ashitani, S., Ohishi, M., Ueno, A., Tomita, M., Ueda, K., Soga, T., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03363-3 · Cited by 20

POU2F2-mediated Upregulation of lncRNA PTPRG-AS1 Inhibits Ferroptosis in Breast Cancer Via miR-376c-3p/SLC7A11 Axis

Li, J., Li, P.-T., Wu, W., Ding, B.-N., Wen, Y., Cai, H.-L., Liu, S., Hong, T., Zhang, J.-F., Zhou, J.-D., et al. (2024) · Epigenomics · doi:10.2217/epi-2023-0100 · Cited by 20

The Wnt Signaling Landscape of Mammary Stem Cells and Breast Tumors

Alexander, C. M. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.11.020 · Cited by 20

BCATc modulates crosstalk between the PI3K/Akt and the Ras/ERK pathway regulating proliferation in triple negative breast cancer

Shafei, M. A., Forshaw, T. E., Davis, J., Flemban, A. F., Qualtrough, D., Dean, S., Perks, C. M., Dong, M., Newman, R. H., & Conway, M. E. (2020) · Oncotarget · doi:10.18632/oncotarget.27607 · Cited by 20

High-Throughput Assay Development for Cystine-Glutamate Antiporter (xc-) Highlights Faster Cystine Uptake than Glutamate Release in Glioma Cells

Thomas, A. G., Sattler, R., TenDyke, K., Loiacono, K. A., Hansen, H. F., Sahni, V., Hashizume, Y., Rojas, C. J., & Slusher, B. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127785 · Cited by 20

Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- Activity

Linher‐Melville, K., Nashed, M. G., Ungard, R. G., Haftchenary, S., Rosa, D. A., Gunning, P. T., & Singh, G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161202 · Cited by 22

Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer

Ciombor, K. K., Bae, S.-W., Whisenant, J. G., Ayers, G. D., Sheng, Q., Peterson, T. E., Smith, G. T., Lin, K., Chowdhury, S., Marie, P. K., et al. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-3133 · Cited by 19

Therapeutic Targeting of Glutaminolysis as a Novel Strategy to Combat Cancer Stem Cells

Kao, T., Chuang, Y.-C., Lee, H., Kuo, C., & Shen, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315296 · Cited by 19

Ketogenic diet as a treatment and prevention strategy for cancer: A therapeutic alternative

Neha, N., & Chaudhary, R. (2024) · Nutrition · doi:10.1016/j.nut.2024.112427 · Cited by 20

A small molecule that induces reactive oxygen species via cellular glutathione depletion

Kawamura, T., Kondoh, Y., Muroi, M., Kawatani, M., & Osada, H. (2014) · Biochemical Journal · doi:10.1042/bj20140669 · Cited by 19

Aberrant Metabolism as Inductor of Epigenetic Changes in Breast Cancer: Therapeutic Opportunities

Coronel-Hernández, J., Pérez-Yépez, E. A., Delgado-Waldo, I., Contreras-Romero, C., Jacobo-Herrera, N. J., León, D. F. C.-D., & Pérez‐Plasencia, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.676562 · Cited by 19

Metabolic Alterations Induced by Kudingcha Lead to Cancer Cell Apoptosis and Metastasis Inhibition

Zhu, S., Wei, L., Lin, G., Tong, Y., Zhang, J., Jiang, X. J., He, Q., Lu, X., Zhu, D. D., & Chen, Y. Q. (2019) · Nutrition and Cancer · doi:10.1080/01635581.2019.1645865 · Cited by 19

Genetic Determinants of Metabolism and Benign Prostate Enlargement: Associations with Prostate Volume

Giri, A., Edwards, T. L., Motley, S. S., Byerly, S. H., & Fowke, J. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132028 · Cited by 19

Mutant p53-reactivating compound APR-246 synergizes with asparaginase in inducing growth suppression in acute lymphoblastic leukemia cells

Ceder, S., Eriksson, S. E., Liang, Y. Y., Cheteh, E. H., Zhang, S. M., Fujihara, K. M., Bianchi, J., Bykov, V. J. N., Abrahmsen, L., Clemons, N. J., et al. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03988-y · Cited by 18

Limiting glutamine utilization activates a GCN2/TRAIL-R2/Caspase-8 apoptotic pathway in glutamine-addicted tumor cells

Yerbes, R., Mora-Molina, R., Fernández-Farrán, F. J., Hiraldo, L., López‐Rivas, A., & Palacios, C. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05346-y · Cited by 19

xCT knockdown in human breast cancer cells delays onset of cancer-induced bone pain

Ungard, R. G., Linher‐Melville, K., Nashed, M. G., Sharma, M., Wen, J., & Singh, G. (2019) · Molecular Pain · doi:10.1177/1744806918822185 · Cited by 18

G protein-coupled kisspeptin receptor induces metabolic reprograming and tumorigenesis in estrogen receptor-negative breast cancer

Dragan, M., Nguyen, M.-U., Guzman, S., Goertzen, C., Brackstone, M., Dhillo, W. S., Bech, P., Clarke, S. A., Abbara, A., Tuck, A. B., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2305-7 · Cited by 19

Regulated lytic cell death in breast cancer

Liu, M., Wang, L., Xia, X., Wu, Y., Zhu, C., Duan, M., Wei, X., Hu, J., & Lei, L. (2021) · Cell Biology International · doi:10.1002/cbin.11705 · Cited by 19

Aberrant L-Fucose Accumulation and Increased Core Fucosylation Are Metabolic Liabilities in Mesenchymal Glioblastoma

Pieri, V., Gallotti, A. L., Drago, D., Cominelli, M., Pagano, I., Conti, V., Valtorta, S., Coliva, A., Lago, S., Michelatti, D., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0677 · Cited by 19

In Vivo Loss of Function Screening Reveals Carbonic Anhydrase IX as a Key Modulator of Tumor Initiating Potential in Primary Pancreatic Tumors

Pore, N., Jalla, S., Liu, Z., Higgs, B. W., Sorio, C., Scarpa, A., Hollingsworth, R. E., Tice, D. A., & Michelotti, E. F. (2015) · Neoplasia · doi:10.1016/j.neo.2015.05.001 · Cited by 18

Nano-delivery of RAD6 /Translesion Synthesis Inhibitor SMI#9 for Triple-negative Breast Cancer Therapy

Saadat, N., Liu, F., Haynes, B. M., Nangia‐Makker, P., Bao, X., Li, J., Polin, L., Gupta, S. V., Mao, G., & Shekhar, M. P. V. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0364 · Cited by 18

The potential therapeutic targets of glutamine metabolism in head and neck squamous cell carcinoma

Guo, S., Wang, X., Wang, Y., Bai, J., Liu, Y., & Shao, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116906 · Cited by 17

Tumour-Derived Glutamate: Linking Aberrant Cancer Cell Metabolism to Peripheral Sensory Pain Pathways

Fazzari, J., Linher‐Melville, K., & Singh, G. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160509123042 · Cited by 16

Control of amino acid transport into Chinese hamster ovary cells

Geoghegan, D., Arnall, C. L., Hatton, D., Noble‐Longster, J., Sellick, C. A., Senussi, T., & James, D. C. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26794 · Cited by 18

Low Doses of Silver Nanoparticles Selectively Induce Lipid Peroxidation and Proteotoxic Stress in Mesenchymal Subtypes of Triple-Negative Breast Cancer

Snyder, C. M., Rohde, M. M., Fahrenholtz, C. D., Swanner, J. L., Sloop, J. T., Donati, G. L., Furdui, C. M., & Singh, R. N. (2021) · Cancers · doi:10.3390/cancers13164217 · Cited by 18

Targeting amino acid metabolism to inhibit gastric cancer progression and promote anti-tumor immunity: a review

Jiang, Y., Qing, T., Qiao, X., Yang, Y., Chen, P., Han, M., Dong, K., Zhang, W., Xu, M., Wang, D., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1508730 · Cited by 18

SLC1A5 is a key regulator of glutamine metabolism and a prognostic marker for aggressive luminal breast cancer

Alfarsi, L. H., Ansari, R. E., Erkan, B., Fakroun, A., Craze, M. L., Aleskandarany, M. A., Cheng, K. W., Ellis, I. O., Rakha, E. A., & Green, A. R. (2025) · Scientific Reports · doi:10.1038/s41598-025-87292-1 · Cited by 16

Novel Antiproliferative Biphenyl Nicotinamide: NMR Metabolomic Study of its Effect on the MCF-7 Cell in Comparison with Cisplatin and Vinblastine

Coco, L. D., Majellaro, M., Boccarelli, A., Cellamare, S., Altomare, C., & Fanizzi, F. P. (2020) · Molecules · doi:10.3390/molecules25153502 · Cited by 16

Ferroptosis and its emerging role in tumor

Wang, X., Liu, Z., Ma, L., & Yu, H. (2021) · Biophysics Reports · doi:10.52601/bpr.2021.210010 · Cited by 15

Adverse Crosstalk between Extracellular Matrix Remodeling and Ferroptosis in Basal Breast Cancer

Desterke, C., Cosialls, E., Xiang, Y., Elhage, R., Duruel, C., Chang, Y., & Hamaï, A. (2023) · Cells · doi:10.3390/cells12172176 · Cited by 15

Mechanisms and therapeutic potential of disulphidptosis in cancer

Li, Y., Zhang, H., Yang, F., Zhu, D., Chen, S., Wang, Z., Wei, Z., Yang, Z., Jia, J., Zhang, Y., et al. (2024) · Cell Proliferation · doi:10.1111/cpr.13752 · Cited by 15

Systematic alteration of in vitro metabolic environments reveals empirical growth relationships in cancer cell phenotypes

Kochanowski, K., Sander, T., Link, H., Chang, J. B., Altschuler, S. J., & Wu, L. F. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108647 · Cited by 16

Overexpression of Cystine/Glutamate Antiporter xCT Correlates with Nutrient Flexibility and ZEB1 Expression in Highly Clonogenic Glioblastoma Stem-like Cells (GSCs)

Koch, K., Hartmann, R., Suwala, A. K., Herrera-Rios, D., Kamp, M. A., Sabel, M., Steiger, H., Willbold, D., Sharma, A., Kahlert, U. D., et al. (2021) · Cancers · doi:10.3390/cancers13236001 · Cited by 15

Drug library screening identifies histone deacetylase inhibition as a novel therapeutic strategy for choriocarcinoma

Watanabe, E., Yokoi, A., Yoshida, K., Sugiyama, M., Kitagawa, M., Nishino, K., Yamamoto, E., Niimi, K., Yamamoto, Y., & Kajiyama, H. (2022) · Cancer Medicine · doi:10.1002/cam4.5243 · Cited by 14

STUB1-mediated ubiquitination regulates the stability of GLUD1 in lung adenocarcinoma

Hu, Q., Lei, J., Cheng, Z., Xu, J., Wang, L., Yuan, Y., Gan, M., Wang, Y., Xie, Y., Yao, L., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107151 · Cited by 14

Insulin Receptor Substrate Adaptor Proteins Mediate Prognostic Gene Expression Profiles in Breast Cancer

Becker, M. A., Ibrahim, Y. H., Oh, A. S., Fagan, D. H., Byron, S. A., Sarver, A. L., Lee, A. V., Shaw, L. M., Fan, C., Perou, C. M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150564 · Cited by 14

Inhibition of Metabolism as a Therapeutic Option for Tamoxifen-Resistant Breast Cancer Cells

Steifensand, F., Gallwas, J. K. S., Bauerschmitz, G. J., & Gründker, C. (2021) · Cells · doi:10.3390/cells10092398 · Cited by 15

The Exosome And Breast Cancer Cell Plasticity

Mao, X., & Jin, F. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s214133 · Cited by 14

Targeting Ferroptosis as the Achilles’ Heel of Breast Cancer: Mechanisms and Therapeutic Opportunities from a Comprehensive Systematic Review

Szulc, A., & Woźniak, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26209902 · Cited by 17

Licochalcone A Induces Ferroptosis in Hepatocellular Carcinoma via Reactive Oxygen Species Activated by the SLC7A11/GPX4 Pathway

Zhang, J., Xiao, Y., Li, Y., Zhu, Y., Li, Y., Zhao, R.-S., Jin, N., Fang, J., Li, X., & Han, J. (2023) · Integrative Cancer Therapies · doi:10.1177/15347354231210867 · Cited by 15

SLC7A9 suppression increases chemosensitivity by inducing ferroptosis via the inhibition of cystine transport in gastric cancer

Feng, H., Yu, J., Xu, Z., Sang, Q., Li, F., Chen, M., Chen, Y., Yu, B., Zhu, N., Xia, J., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105375 · Cited by 14

Functional Proteomics of Breast Cancer Metabolism Identifies GLUL as Responder during Hypoxic Adaptation

Bernhardt, S., Tönsing, C., Mitra, D., Erdem, N., Müller‐Decker, K., Korf, U., Kreutz, C., Timmer, J., & Wiemann, S. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00944 · Cited by 13

Functional Consequences of Low Activity of Transport System A for Neutral Amino Acids in Human Bone Marrow Mesenchymal Stem Cells

Chiu, M., Taurino, G., Bianchi, M. G., Dander, E., Fallati, A., Giuliani, N., D’Amico, G., & Bussolati, O. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051899 · Cited by 13

Suppression of the xCT-CD44v antiporter system sensitizes triple-negative breast cancer cells to doxorubicin

Yang, F. (2014) · Cited by 13

The tumour suppressor CCDC6 is involved in ROS tolerance and neoplastic transformation by evading ferroptosis

Morra, F., Merolla, F., Marino, F. Z., Catalano, R., Franco, R., Chieffi, P., & Celetti, A. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e08399 · Cited by 14

MRI assessment of glutamine uptake correlates with the distribution of glutamine transporters and cancer stem cell markers

Seo, Y., Kang, J., Kim, T. I., & Joo, C. G. (2022) · Scientific Reports · doi:10.1038/s41598-022-09529-7 · Cited by 13

Hormone-Glutamine Metabolism: A Critical Regulatory Axis in Endocrine-Related Cancers

Xu, F., Shi, J., Qin, X., Zheng, Z., Chen, M., Lin, Z., Ye, J., & Li, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710086 · Cited by 15

An anti-CD98 antibody displaying pH-dependent Fc-mediated tumour-specific activity against multiple cancers in CD98-humanized mice

Tian, X., Liu, X., Ding, J., Wang, F., Wang, K., Liu, J., Wei, Z., Hao, X., Li, Y., Wei, X., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00956-5 · Cited by 13

Identification of common key genes in breast, lung and prostate cancer and exploration of their heterogeneous expression

Makhijani, R., Raut, S., & Purohit, H. (2017) · Oncology Letters · doi:10.3892/ol.2017.7508 · Cited by 13

Sulfasalazine Sensitizes Polyhematoporphyrin-Mediated Photodynamic Therapy in Cholangiocarcinoma by Targeting xCT

Zheng, Y., Miao, X., Xiong, L., Chen, B., Kong, F., Zhou, J., Liu, Z.-T., Wen, Y., Zhang, Z., & Zou, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.723488 · Cited by 13

Metabolic Phenotypes, Dependencies, and Adaptation in Lung CancerPreprint

DeNicola, G. M., & Shackelford, D. B. (2021) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a037838 · Cited by 13

Glutaminolysis and α-ketoglutarate-stimulated KCa3.1 expression contribute to β-adrenoceptor activation-induced myocardial fibrosis in mice

Bai, R., Wu, L., Wang, Y., Guo, C., She, G., Pang, Z., Li, J.-J., Zhao, X.-Y., Han, M.-Z., Hai, X.-X., et al. (2025) · Science China Life Sciences · doi:10.1007/s11427-024-2811-x · Cited by 12

Abstract B20: Glutamine metabolic vulnerabilities define triple-negative from luminal A breast cancer subsets

van Geldermalsen, M., Quek, L., Turner, N. A., Balaban, S., Hoy, A. J., Wang, Q., & Holst, J. (2018) · Molecular Cancer Research · doi:10.1158/1557-3125.advbc17-b20

Targeting xCT with sulfasalazine suppresses triple-negative breast cancer growth via inducing autophagy and coordinating cell cycle and proliferation

Long, Y., Xu, Z., Yu, J., Hu, X., Xie, Y., Duan, X., Li, N., Yan, Y., Wang, Y., & Qin, J. (2024) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000001630 · Cited by 9

Abstract P3-02-09: Vulnerabilities in glutamine metabolism define triple-negative from Luminal A breast cancer subsets

van Geldermalsen, M., Quek, L., Turner, N. A., Balaban, S., Hoy, A. J., Pang, A., Guan, Y. F., Wahi, K., Wang, Q., & Holst, J. (2020) · Cancer Research · doi:10.1158/1538-7445.sabcs19-p3-02-09

Targeting the ASCT2 glutamine uptake and metabolism pathway in triple-negative breast cancer

van Geldermalsen, M., Wang, Q., Bailey, C. G., Feng, Y., Nagarajah, R., Marshall, A. D., Thoeng, A., O’Toole, S. A., Rasko, J. E. J., & Holst, J. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv121.04

Glutamine Transporter Expression Profiling in Murine Breast Cancer Reveals Therapeutic Targets for Triple Negative Breast Cancer

Kron, C., & Bode, B. P. (2017) · The FASEB Journal · doi:10.1096/fasebj.31.1_supplement.809.6